Ryuji Yokokawa's Biography

• Home
• |
• Registration
• |
• Submissions
  • Submission Guidelines
• |
• Agenda
• |
• Exhibition
• |
• Venue
• |
• Short Courses
  • Training Courses
• |
• Co-Located Conferences
• |
• Media
• |

Microphysiological Systems (MPS) With Perfusable Vascular Network for Pharmacological and Organogenesis Applications

Friday, 6 October 2023 at 15:00

Add to Calendar ▼2023-10-06 15:00:002023-10-06 16:00:00Europe/LondonMicrophysiological Systems (MPS) With Perfusable Vascular Network for Pharmacological and Organogenesis ApplicationsLab-on-a-Chip and Microfluidics Asia 2023 in Tokyo, JapanTokyo, JapanSELECTBIOenquiries@selectbiosciences.com

Microfluidic devices have been used to answer scientific questions in many lifescience research fields. Microphysiological systems (MPS) mimics the functions of human biological organs and can be used to measure physiological functions that are difficult to measure on a culture dish. We have employed two approaches to create the interface between organ cells and vascular networks: a two-dimensional method in which organ cells and vascular endothelial cells are co-cultured on a porous membrane such as Transwell (2D-MPS), and a three-dimensional method in which the spontaneous patterning ability of vascular endothelial cells is utilized (3D-MPS). As an example of 2D-MPS, we developed a renal proximal tubule model and a glomerular filtration barrier model using iPSC-derived organoid cells, which enables us to evaluate reabsorption, filtration, and nephrotoxicity. For 3D-MPS, angiogenesis and/or vasculogenesis are utilized to anastomose a fibroblast spheroid and tumor spheroids to create tumor microenvironments to evaluate the efficacy of an anti-tumor drug under a flow condition. We also developed an on-chip vascular bed to co-culture with any kind of tissues that do not have enough angiogenic factors to induce angiogenesis. It was applied to kidney and brain organoids for evaluating the effect of vessels on their development. The vascular bed chip enabled to culture a kidney organoid at the air-liquid interface (ALI) that is required for nephrogenesis and to separately supply two media for the organoid and vascular bed. Proposed assay platforms will further contribute to realize pharmacological applications and to understand in vivo organogenesis. We keep exploring how micro/nano fabrications can deepen science at the interface between blood vessels and organs.